Product Information
HYDROMORPHONE 1 MG/ML SOLUTION is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.2359 per ML under NDC 00054038663. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Jul 29, 1998. Its Orange Book therapeutic-equivalence code is AA.
Strength
1 mg/mL
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054038663
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
HYDROMORPHONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA074653FDA Approved
7/29/1998
TE Code
AA
On Market Since
3/1/2012
Pharmacological Classes
Price Statistics
The NADAC for HYDROMORPHONE 1 MG/ML SOLUTION has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 20.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2359 per ML |
|---|---|
| All-time high | $0.4064 (Oct 12, 2016) |
| All-time low | $0.2058 (Mar 22, 2023) |
| 52-week high | $0.3015 |
| 52-week low | $0.2359 |
| Median price | $0.2842 |
| Average price | $0.2796 |
| Largest weekly change | +39.4% (Jun 21, 2023) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the hydromorphone hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hikma Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
hydromorphone hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HYDROMORPHONE 1 MG/ML SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for HYDROMORPHONE 1 MG/ML SOLUTION, manufactured by Hikma Pharmaceuticals USA Inc., is $0.2359 per ML (NDC 00054038663), effective Sep 30, 2026.
How has the price of HYDROMORPHONE 1 MG/ML SOLUTION changed over time?
Over the history we have for it, the NADAC for HYDROMORPHONE 1 MG/ML SOLUTION has declined 20.4%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for HYDROMORPHONE 1 MG/ML SOLUTION?
Since Nov 28, 2013, the NADAC for HYDROMORPHONE 1 MG/ML SOLUTION has ranged from a low of $0.2058 (Mar 22, 2023) to a high of $0.4064 (Oct 12, 2016), with a median of $0.2842 per ML.
Are there cheaper alternatives to HYDROMORPHONE 1 MG/ML SOLUTION?
No other NADAC-published product currently shares the active ingredient and strength of HYDROMORPHONE 1 MG/ML SOLUTION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures HYDROMORPHONE 1 MG/ML SOLUTION?
HYDROMORPHONE 1 MG/ML SOLUTION (NDC 00054038663) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.